Transparencia de precios

Llame al (844) 424 a 4537

All Clinical Trials

Clinical Trial

AALL1621: A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)

  • Recruiting participants (Starts Jun. 14, 2017)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: Tamra Lynn Slone

Participate

If you are interested in this clinical trial, please contact Anil Shalwani on the Children’s Health Research Team.Llame al 214-456-7353Correo electrónico